CurrentRheuma
Get Weekly

Topic · page 6 of 17

Osteoporosis & bone health

Postmenopausal, male and glucocorticoid-induced osteoporosis, fracture risk assessment and bone density, fragility fractures and their secondary prevention, anti-resorptive and anabolic drugs, treatment sequence and drug holidays

Briefs 201–240 of 659 placed here, newest publication first

Briefs in Osteoporosis & bone health

Newest publication first

  1. Joint Bone Spine

    Temporal evolution of publication bias in drug safety assessment: A case study on association between osteonecrosis of the jaw and bisphosphonates

    Meta-analysis

  2. Lancet Rheumatol

    The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021

    Meta-analysis

  3. Lupus Sci Med

    Prevalence and determinants of vertebral fractures in a SLE cohort

    Cross-sectional study

  4. Osteoporos Int

    Height loss, back pain and severe pain are highly predictive of pregnancy associated osteoporosis

    Case-control study

  5. Osteoporos Int

    Adequacy of pharmacological prescription in patients at very high risk of fracture within the FLS in Spain: analysis of the REFRA FLS-SEIOMM Registry

    Cohort study

  6. Osteoporos Int

    The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans—a histomorphometry centered scoping review

    Research article

  7. Osteoporos Int

    Predictive capacity of fracture risk assessment tools: overview of systematic reviews

    Research article

  8. Osteoporos Int

    Incidence, risk factors, prognosis of periprosthetic fractures post hip fracture: unveiling protective role of anti-osteoporotic medication

    Cohort study

  9. Osteoporos Int

    Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab

    Cohort study

  10. Osteoporos Int

    Latin American patients’ perceptions on osteoporosis diagnosis and treatment: The IOF Patient Advisory Group in Latin America

    Cross-sectional study

  11. Osteoporos Int

    The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose

    Cohort study

  12. Osteoporos Int

    Effectiveness of treatment initiation for secondary fracture prevention in the older population: Japanese Bone-fracture Osteoporosis in Late-stage population Database study (J-BOLD) – emulation of a randomized target trial

    Cohort study

  13. Osteoporos Int

    Artificial intelligence system for predicting areal bone mineral density from plain X-rays

    Diagnostic or prognostic study

  14. Osteoporos Int

    Assessing endocrinology referral rates and osteoporosis directed-care after upper extremity fragility fractures

    Cohort study

  15. Osteoporos Int

    Family history of fracture and fracture risk: a meta-analysis to update the FRAX® risk assessment tool

    Meta-analysis

  16. Osteoporos Int

    Impact of anti-osteoporosis medication on refracture prevention following osteoporotic vertebral fracture: a systematic review and meta-analysis

    Meta-analysis

  17. Osteoporos Int

    Increased all-cause mortality following proximal humerus fractures in Danish adults: a register-based matched cohort study of 93,952 fracture cases and 469,760 controls

    Cohort study

  18. Osteoporos Int

    Barriers and solutions for global access to osteoporosis management: a Position Paper from the International Osteoporosis Foundation

    Guideline or statement

  19. Rheumatology (Oxford)

    The Michael Mason prize: development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicine

    Research article

  20. Osteoporos Int

    Performance and interventional cutoffs of osteoporosis self-assessment tools in the community: implications for screening and early referral

    Diagnostic or prognostic study

  21. Osteoporos Int

    Lung-related risk factors associate with low bone mineral density in individuals with former tobacco exposure not meeting osteoporosis screening criteria

    Cross-sectional study

  22. Osteoporos Int

    The impact of direct oral anticoagulants on hip fracture care in Australia and New Zealand: a prospective patient sprint audit

    Cohort study

  23. Osteoporos Int

    Femur geometry influences atypical femoral fracture location

    Cross-sectional study

  24. Osteoporos Int

    Diminishing returns of fall reduction for hip fracture prevention in older age

    Meta-analysis

  25. Osteoporos Int

    Long-term trends of osteoporotic hip fractures in South Korea: analysis of National Health Insurance Data from 2006 to 2022

    Cohort study

  26. Osteoporos Int

    A cost-saving analysis of pharmacologic management in osteoporotic fracture prevention among postmenopausal women

    Meta-analysis

  27. JAMA Netw Open

    Adolescent Body Mass Index, Weight Trajectories to Adulthood, and Osteoporosis Risk

    Cohort study

  28. Osteoporos Int

    DXA based radiomics scoring: a novel approach for fragility fracture risk assessment in elderly type 2 diabetes patients

    Diagnostic or prognostic study

  29. Osteoporos Int

    Incidence of hip fractures in persons with and without Parkinson’s disease in Finland: a 15-year longitudinal study

    Cohort study

  30. Arthritis Res Ther

    Lupus nephritis and U1-RNP-antibodies are associated with low bone mineral density and osteoporosis in patients with systemic lupus erythematosus: baseline findings in a sub-cohort of patients with inflammatory rheumatic diseases

    Cross-sectional study

  31. Osteoporos Int

    Fatty acid dietary intakes and blood concentrations in relation to hip fracture risk in adults: a systematic review and meta-analysis of prospective cohort studies

    Meta-analysis

  32. Osteoporos Int

    Quantitative computed tomography provides improved accuracy for diagnosis of lumbar osteoporosis in patients with facet joint osteoarthritis: a cross-sectional study

    Cross-sectional study

  33. Osteoporos Int

    Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study

    Cohort study

  34. Osteoporos Int

    OsteoStrong and bone health: a scoping review

    Research article

  35. Osteoporos Int

    Testosterone, sex hormone-binding globulin, and fracture risk in men: evidence from observational and Mendelian randomization analyses

    Cohort study

  36. Osteoporos Int

    Clinical and health-economic impact of orthogeriatric care models in Belgium: A population-based data registry study

    Cohort study

  37. Osteoporos Int

    Contemporary pharmacological management of patients after hip fracture: a population-based cohort of over 120,000 patients in Spain

    Cohort study

  38. Osteoporos Int

    Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumab

    Cohort study

  39. Osteoporos Int

    Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis

    Cohort study

  40. Osteoporos Int

    Effect of FRAXplus adjustments on fracture risk reclassification in older Swedish women—results from the SUPERB-study

    Cohort study

All 659 Briefs in ExploreShowing Briefs 201–240 of 659, newest first